P44 Aims: Organ procurement in living donor liver transplantation (LDLTx) is usually well controlled, and allows to assess the quality of liver preservation as well as early graft function under standardized conditions. Since publications on histidine-tryptophan-ketoglutarate solution (HTK) are limited, we prospectively studied its safety and efficacy in LDLTx. Methods: This consecutive series included 23 patients (20 adults, 3 children; age 9 mo-61 yr), suffering from end-stage cirrhosis (16), malignant liver tumors (6), and acute hepatic failure (1), respectively. All donors (age 22-69 yr) had normal liver function tests, including six with steatosis of 5-20 %. The donor operation was performed by the same surgeon, and resulted in 21 right lobes, one left lobe, and one left lateral graft (graft weight 836±213 g). Liver preservation was done in a standard fashion by gravity perfusion with HTK, starting in situ through the portal vein (4.6±1.0 L), and continued on the backtable with infusion via the hepatic artery (1.0±0.5 L), for 10 min each to allow for adequate electrolyte equilibration. Aditionally, the bile ducts were flushed with HTK. Results: First and second warm ischemia times were <1 min, and 39±15 min, respectively; total ischemia time was 195±66 min. There was no primary non-function in this series, and all liver grafts showed good recovery with peak aspartate aminotransferase 589±498 U/L, total bilirubin 15.94±8.29 mg/dL, and partial thromboplastin time 49.90±9.58 sec. One graft was lost from parenchymal rupture secondary to portal hyperperfusion, and the patient was successfully retransplanted after six days. 30-day mortality was 13 %, and included pancreatitis, hepatic artery rupture, and sudden cardiac death. 7/23 recipients developed early biliary leakage after 8-45 d from the resectional surface, and following multiple duct reconstructions. There was no late ischemic type biliary complication. Conclusions: These results confirm earlier observations that HTK solution is safe and effective, also when used in LDLTx. Potential advantages of HTK in comparison to other preservation solutions are: low potassium concentration, low viscosity, high flow, fast cooling, ready to use, no particles, in situ perfusion, no flush before reperfusion, improved biliary protection, better recovery of microcirculatory changes, and lower costs. Since the risk-benefit ratio is of particular importance in LDLTx the use of HTK solution should be encouraged.